Skip to main content
High RiskFDAfda-F-2377-2014UNDECLARED ALLERGEN

CRAZY JERRY"S DA BIG CHEESE; NET WT. 16 OZ. ( 1 LB.) 454g; Prepared for Crazy Jerry's Inc. P.O. Box 891 Roswell, GA 30077

Category
Units Affected
504
Recall Date
February 25, 2014
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2377-2014.

Undeclared Wheat due to a supplier's inadvertent use of a wheat product instead of whey in preparing the cheese pre-mix for the recalling firm.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2377-2014.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Creative Foodworks, Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2377-2014.

Creative Foodworks, Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Creative Foodworks, Inc Recall FAQ

Creative Foodworks, Inc is the subject of a dairy safety report: CRAZY JERRY"S DA BIG CHEESE; NET WT. 16 OZ. ( 1 LB.) 454g; Prepared for Crazy Jerry's Inc. P.O. Box 891 Roswell, GA 30077. The notice was published on February 25, 2014 by the U.S. Food and Drug Administration (FDA). Approximately 504 units are potentially affected.